AREV
EURONEXT:AREV
AREV Life Sciences Global Corp.
- Stock
Last Close
0.09
23/07 20:00
Market Cap
2.13M
Beta: 2.94
PE Ratio
−11.93
PFCF: −13.88
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 44.75K - | 22.38K 50% | 11.44K - | 32.38K 182.99% | 20.94K 35.34% | 2.31K - | 12.30K 431.48% | 9.99K 18.82% | |||
average payables | 894.50 - | 7.84K 776.86% | 32.81K 318.27% | 75.88K 131.30% | 169.24K 123.02% | 208.25K 23.05% | 243.05K 16.71% | 369.81K 52.15% | 491.25K 32.84% | 677.52K 37.92% | |
average receivables | 2.12K - | 1.32K 37.59% | 2.94K 122.56% | 7.69K 161.27% | 24.84K 222.85% | 239.31K 863.51% | 230.84K 3.54% | 24.14K 89.54% | 77.71K 221.93% | 88.87K 14.36% | |
book value per share | -0.91 - | -13.93 1,433.20% | -32.12 130.55% | 17.82 155.49% | 0.40 97.77% | -0.04 109.95% | -0.06 48.67% | -0.04 28.90% | -0.00 88.56% | ||
capex per share | -0.63 - | -0.44 29.41% | -0.05 89.41% | -0.01 81.35% | -0.02 175.40% | -0.03 23.66% | -0.00 97.93% | ||||
capex to depreciation | -8.99 - | -0.63 92.97% | -2.19 246.68% | -0.95 56.51% | -3.28 244.23% | -3.07 6.46% | -0.08 97.32% | -0.65 692.49% | |||
capex to operating cash flow | 0.07 - | 0.04 37.88% | 0.25 516.42% | 0.04 84.17% | 1.89 4,636.22% | 19.40 926.01% | 0.01 99.96% | 0.29 3,412.73% | |||
capex to revenue | -1.10 - | -2.39 116.67% | -0.05 98.03% | -1.67 3,428.53% | |||||||
cash per share | 1.07 - | 0.30 72.46% | 0.34 13.94% | 18.83 5,497.58% | 0.44 97.67% | 0.00 99.67% | 0.00 126.94% | 0.02 484.62% | 0.01 58.28% | ||
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | 40.94 - | 50.64 23.69% | 184.62 264.58% | 362.43 96.31% | |||||||
debt to assets | 2.99 - | 0.46 84.68% | 0.17 62.50% | 0.81 370.02% | 0.65 19.20% | 0.58 11.57% | 0.12 78.89% | 0.11 6.19% | |||
debt to equity | -0.32 - | 1.98 727.28% | 0.30 84.99% | -1.89 736.42% | -1.09 42.28% | -1.15 5.29% | -0.81 29.43% | -0.03 96.26% | |||
dividend yield | |||||||||||
earnings yield | -0.19 - | -0.40 109.66% | -0.50 25.85% | -24.65 4,796.80% | -0.12 99.51% | -0.98 708.29% | -1.74 77.26% | -0.24 86.39% | -0.17 27.79% | ||
enterprise value | 172.43K - | 186.35K 8.07% | 217.26K 16.59% | 179.43K 17.41% | 7.64M 4,158.46% | 9.02M 18.06% | 2.42M 73.13% | 5.12M 111.35% | 5.99M 16.89% | 28.74K 99.52% | |
enterprise value over ebitda | -5.14 - | -6.30 22.57% | -2.66 57.72% | -0.82 69.19% | -9.58 1,068.14% | -5.51 42.53% | -0.82 85.13% | -10.16 1,140.32% | -3.94 61.21% | -0.02 99.43% | |
ev to operating cash flow | -6.02 - | -44.90 645.85% | -4.47 90.04% | -1.61 63.93% | -17.05 957.16% | -7.20 57.76% | -21.31 195.92% | -217.88 922.39% | -4.07 98.13% | -0.10 97.52% | |
ev to sales | 12.45 - | 26.89 115.91% | 23.49 12.64% | 0.59 97.51% | |||||||
free cash flow per share | -5.25 - | -0.72 86.26% | -10.12 1,303.60% | -11.23 10.97% | -0.23 97.93% | -0.23 2.11% | -0.04 83.84% | -0.03 14.95% | -0.08 142.32% | ||
free cash flow yield | -0.16 - | -0.02 86.26% | -0.31 1,303.60% | -11.34 3,561.92% | -0.07 99.41% | -0.15 127.10% | -0.17 15.45% | -0.10 41.44% | -0.24 138.41% | ||
graham net net | -5.24 - | -14.06 168.19% | -34.51 145.46% | -38.45 11.42% | 0.17 100.44% | -0.07 143.14% | -0.15 107.99% | -0.10 31.43% | -0.02 77.87% | ||
graham number | 11.29 - | 64.00 466.96% | 109.01 70.34% | 98.92 9.26% | 1.94 98.04% | 1.14 41.11% | 0.69 39.26% | 0.26 62.50% | 0.08 71.03% | ||
income quality | 0.84 - | 0.06 93.45% | 0.58 946.41% | 0.44 23.43% | 0.44 0.61% | 0.15 66.17% | 0.04 76.03% | 0.02 37.07% | 1.48 6,520.43% | 0.20 86.73% | |
intangibles to total assets | 0 - | 0 | 0 | 0.19 Infinity% | 0 100% | 0.00 Infinity% | 0 100% | 0 | 0 | 0 | |
interest coverage | -175.24 - | -97.87 44.15% | -37.04 62.15% | -8.79 76.27% | -22.51 156.08% | -42.09 87.02% | -41.33 1.81% | -11.10 73.13% | -36.05 224.66% | -229.06 535.36% | |
interest debt per share | 0.04 - | 0.05 49.82% | 10.55 19,816.61% | 37.73 257.51% | 0.13 99.65% | 0.08 38.60% | 0.07 11.54% | 0.05 28.31% | 0.01 87.96% | ||
inventory turnover | |||||||||||
invested capital | -0.32 - | 1.98 727.28% | 0.30 84.99% | -1.89 736.42% | -1.09 42.28% | -1.15 5.29% | -0.81 29.43% | -0.03 96.26% | |||
market cap | 178.28K - | 188.05K 5.48% | 167.17K 11.10% | 10.21K 93.89% | 8.41M 82,327.77% | 8.60M 2.22% | 1.88M 78.13% | 4.69M 149.12% | 6.07M 29.59% | ||
net current asset value | -5.53K - | -80.18K 1,350.98% | -167.18K 108.50% | -366.44K 119.19% | 492.06K 234.28% | -226.45K 146.02% | -1.32M 482.75% | -1.06M 19.67% | -377.94K 64.35% | -1.14M 201.27% | |
net debt to ebitda | 0.17 - | 0.06 67.05% | -0.61 1,169.13% | -0.77 26.04% | 0.97 225.45% | -0.26 126.37% | -0.18 28.28% | -0.87 373.38% | 0.05 106.25% | -0.02 141.69% | |
net income per share | -6.23 - | -13.07 109.66% | -16.45 25.85% | -24.40 48.39% | -0.42 98.27% | -1.47 248.40% | -0.36 75.18% | -0.07 80.23% | -0.05 26.61% | ||
operating cash flow per share | -5.25 - | -0.72 86.26% | -9.49 1,216.87% | -10.79 13.63% | -0.19 98.28% | -0.22 17.87% | -0.01 94.19% | -0.00 87.95% | -0.08 4,802.44% | ||
payables turnover | |||||||||||
receivables turnover | 8.92 - | 7.21 19.16% | 1.98 72.57% | 1.01 49.06% | |||||||
research and ddevelopement to revenue | 5.90 - | 0.67 88.62% | 0.58 13.40% | 1.71 194.10% | |||||||
return on tangible assets | -0.64 - | -21.47 3,233.61% | -4.85 77.40% | -0.39 91.96% | -0.61 57.63% | -15.89 2,484.86% | -3.71 76.63% | -0.87 76.65% | -1.66 91.96% | -5.72 243.33% | |
revenue per share | 0.02 - | 0.01 42.93% | 0.01 4.94% | ||||||||
roe | 6.86 - | 0.94 86.33% | 0.51 45.42% | -1.37 367.44% | -1.06 22.36% | 37.21 3,599.91% | 6.21 83.31% | 1.73 72.19% | 11.09 541.70% | 1.52 86.32% | |
roic | 6.82 - | 0.37 94.52% | 0.72 92.12% | -0.41 157.51% | -0.56 35.46% | -1.73 208.47% | -65.32 3,685.29% | -3.55 94.57% | -50.45 1,322.28% | 1.52 103.01% | |
sales general and administrative to revenue | 10.09 - | 2.95 70.78% | 5.65 91.66% | 20.08 255.36% | |||||||
shareholders equity per share | -0.91 - | -13.93 1,433.20% | -32.12 130.55% | 17.82 155.49% | 0.40 97.77% | -0.04 109.95% | -0.06 48.67% | -0.04 28.90% | -0.00 88.56% | ||
stock based compensation to revenue | 5.45 - | 0.56 89.80% | 1.79 221.22% | 2.94 64.39% | |||||||
tangible asset value | -4.96K - | -80.18K 1,517.20% | -164.34K 104.96% | 34.90K 121.24% | 959.26K 2,648.35% | -226.45K 123.61% | -525.79K 132.19% | -641.23K 21.96% | -93.51K 85.42% | -952.61K 918.75% | |
tangible book value per share | -0.91 - | -13.93 1,433.20% | -32.12 130.55% | 3.38 110.54% | 0.40 88.28% | -0.04 109.95% | -0.06 48.67% | -0.04 28.90% | -0.00 88.56% | ||
working capital | -5.53K - | -80.18K 1,350.98% | -167.18K 108.50% | -3.08K 98.16% | 776.73K 25,326.83% | -226.45K 129.15% | -1.32M 482.75% | -1.01M 23.63% | -377.94K 62.50% | -1.14M 201.27% |
All numbers in (except ratios and percentages)